|
 |
Excessive Caution on FDA Approval May be Risky
|
 |
|
|
 |
Posted 2007-07-17, 06:17 PM
|
 |
 |
 |
The Food and Drug Administration (FDA) is responsible for regulating "food, dietary supplements, drugs, biological medical products, blood products, medical devices, radiation-emitting devices, veterinary products, and cosmetics in the United States." [1]
In 1992, congress passed legislation which imposed FDA user fees on pharmaceutical companies in order to expedite the process of drug approval. With the influx in income the FDA hired 1000 new employees cutting down drug review time from 30 months to 15.
Critics claim that such legislation practically makes the FDA subordinate to drug companies and endangers public health by rushing drugs onto the market. Criticism from senators and other influential people has made the FDA more timid in approving drugs. According to a 2005 issue of The Journal of the American Medical Association "It does seem indisputable that there have been shifts in the acceptable threshold for risk/benefit for many diseases as the depth of scientific understanding increases and as information about the effects of drugs on large patient populations is more readily available." [2] The time from application to approval nearly doubled from 2004 to 2005.
Initially, this change may appear beneficial. The facts, however, seem to make this conclusion an example of how intuition may be misleading. A study conducted by the University of Chicago claims that the expeditious drug approval may have saved 180,000 to 300,000 life-years, while at worst 56,000 life years were lost. [3] However, it is far easier to identify and emphasize cases where drugs have killed rather than where drugs have saved.
[1] http://en.wikipedia.org/wiki/FDA
[2] http://jama.ama-assn.org/cgi/content/full/294/11/1333
[3] http://www.nber.org/digest/jun06/w11724.html
|
 |
 |
 |
|
|
|
|
|
|
|